Long-Term Neurodevelopmental Outcomes in Children and Adolescents With Congenital Heart Disease

Jeanette M Jerrell1, C Osborne Shuler1, Avnish Tripathi2

  • 1Departments of Neuropsychiatry and Behavioral Science and Pediatrics, University of South Carolina School of Medicine, Columbia.

Insights

Children with congenital heart disease (CHD) have lower risks of most neurodevelopmental disorders but higher seizure risks. Surgical intervention and hypoxemia increase risks for various neurodevelopmental issues in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Health Services Research

Background:

  • Effective management of pediatric congenital heart disease (CHD) is crucial for preventing adverse neurodevelopmental outcomes.
  • Identifying predictors of neurodevelopmental issues in children with CHD is a key healthcare objective.

Purpose of the Study:

  • To identify clinical predictors associated with an increased risk of long-term neurodevelopmental outcomes in children with CHD.
  • To compare neurodevelopmental outcomes in children with CHD to the general pediatric Medicaid population.

Main Methods:

  • Retrospective analysis of 15-year South Carolina Medicaid data (1996-2010).
  • Comparison of 19,947 patients with CHD to 19,948 matched controls without CHD.
  • Logistic and Cox proportional hazards regression models were used.

Main Results:

  • The CHD cohort showed lower odds of neurologic/psychiatric disorders, mental retardation, developmental delays, and inattention/hyperactivity.
  • The CHD cohort had higher odds of incident seizures compared to controls.
  • Surgical intervention (cardiac and noncardiac) and hypoxemia were associated with increased risks of several neurodevelopmental conditions.

Conclusions:

  • Vigilant surveillance for neurodevelopmental issues is essential for all children with CHD.
  • Early identification and prompt management of neurodevelopmental problems are critical, especially for those with surgical exposure or hypoxemia.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
650
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K